Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24041288 | 0.88 | ALOX5 (0.39) | KDM4EATML3MBTL1ALDH1A1ALOX5 | |
| SCHEMBL26536780 | 0.84 | ALOX5 (0.50) | KDM4EATML3MBTL1ALDH1A1ALOX5 | |
| SCHEMBL5030179 | 0.84 | ALOX5 (0.36) | KDM4EATML3MBTL1ALDH1A1ALOX5 | |
| SCHEMBL5028292 | 0.84 | ALOX5 (0.41) | KDM4EATML3MBTL1ALDH1A1ALOX5 | |
| SCHEMBL21147966 | 0.83 | ALOX5 (0.46) | KDM4EATML3MBTL1ALDH1A1ALOX5 | |
| SCHEMBL10038503 | 0.82 | KDM4E (0.43) | KDM4EATML3MBTL1ALDH1A1MEN1 | |
| SCHEMBL24067180 | 0.82 | ALOX5 (0.45) | KDM4EATML3MBTL1ALDH1A1ALOX5 | |
| SCHEMBL21583628 | 0.81 | ALOX5 (0.49) | KDM4EATML3MBTL1ALDH1A1ALOX5 | |
| SCHEMBL10092195 | 0.80 | ALOX5 (0.46) | KDM4EATML3MBTL1ALDH1A1ALOX5 | |
| SCHEMBL20412455 | 0.80 | ALOX5 (0.50) | KDM4EATML3MBTL1ALDH1A1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130119360-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | MERCK PATENT GMBH (DE) | 2013-05-16 | — | — | US | disclosed |
| US-8367224-B2 | Organic electroluminescence element, new compound for the same, display device and lighting device using the same | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-02-05 | — | — | US | disclosed |
| EP-2453496-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, NOVEL COMPOUND, LIGHTING DEVICE AND DISPLAY DEVICE | Konica Minolta Holdings, Inc. (JP) | 2012-05-16 | — | — | EP | disclosed |
| US-20110006670-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110006670-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | AOC2, AOC3, CDYL | KDM4E 367/4885ATM 3194/4885L3MBTL1 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.